Skip to content

findings in patients of topical steroid damaged face

Dermoscopic findings in patients of Topical steroid damaged face treated with Intense pulse light(590nm) -a comparative hospital based study - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/068071
Enrollment
64
Registered
2024-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

Intervention1: Intense pulse light: IPL systems are high intensity light sources which emit polychromatic light. They work with noncoherent light in a broad wavelength spectrum of 515-1200 nm. In vasc
hence larger areas can be treated efficiently with less discomfort. The different filter settings enable a higher selection of a broad range of vessel colors of the vascular system. The longer wavelen

Sponsors

Sri Ram Murti Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients allowing to take photographs. Age group between 18-40 years. Patients using over the counter topical steroids for at least 1 month Diagnosis of TSDF confirmed by 2-3 Dermatologists

Exclusion criteria

Exclusion criteria: Subjects with any other co-morbid dermatological illness.(rosacea, dermatitis, acne). Patient using systemic steroids for more than 1 month. Patient using over the counter skin lighting preparation. • Patients with pregnancy, polycystic ovaries, Cushing’s syndrome, thyroid disorders.

Design outcomes

Primary

MeasureTime frame
Visual Assessment of pre & post procedure photographs will be done by two blinded dermatologists and will be measured by four scores Visual analogue scale for severity of erythema Visual analogue scale for severity of telengectasia Telengectasia count dermoscopy assisted TSDF severity score melasma area severity indexTimepoint: baseline,3 weeks,6 weeks,9 weeks

Secondary

MeasureTime frame
• Dermoscopic assessment will be done using dermlite 4 in a pre defined area which will be the mid point of the line taken from the mid point of two lines i.e line joining the lateral canthus to tragus & a line joining ala of nose to angle of mandible in patients of both groups on each follow up and findings will be noted down and comparedTimepoint: baseline, 3 weeks, 6 weeks, 9 weeks

Countries

India

Contacts

Public ContactDR Stuti Chhawchharia

Department of dermatology, SRMS IMS

dr.pratikg.srmsims@gmail.com9319758004

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026